Last reviewed · How we verify
IVIEW-1201
At a glance
| Generic name | IVIEW-1201 |
|---|---|
| Also known as | Treatment Arm |
| Sponsor | IVIEW Therapeutics Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis (PHASE2)
- Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis (PHASE2)
- Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |